Yashi

  Market Highlights With the growing awareness of early diagnosis, advanced treatment and growing novel drugs to treat the women health disorders among the patients and healthcare professionals has supported the growth of the market.  The health of women is of particular concern as in many societies women are disadvantaged by discrimination rooted in sociocultural factors. For instance, women and girls face increased vulnerability to HIV/AIDS. Globally, women healthcare market is dominated by several major players such as Allergan, Amgen, Bayer, BD, Eli Lily, Merck, Pfizer, Teva Pharmaceuticals and others. APAC region was the most benefited region due to the rising prevalence of the disease and rising number of treatment for women associated diseases and increasing advanced devices and therapeutics for gynecological disorders. The market for women healthcare marketing report is projected to grow at a steady CAGR of 5.04% during the forecast period from 2017-2023. lobal Women He

  Global Population Health Management Market - Overview Population health management is the aggregation and analysis of patient data across multiple health domains and data resources, so as to improve both clinical and financial outcomes. The explosive growth of healthcare data availability which includes clinical data, market data etc. is creating a new set of opportunities and challenges for healthcare industry. The global population health management market is growing with the rapid pace; mainly due to the technological innovation. According to a recent study report published by the Market Research Future, the global population health management is booming and expected to gain prominence over the forecast period growing rapidly. The market is forecasted to demonstrate a spectacular growth by 2023, surpassing its previous growth records in terms of value with a striking CAGR during the anticipated period (2017 – 2023). Notably, extreme need to fill in the gap between expenditu

  Overview The Clinical Laboratory Test market is growing mainly due to growing awareness, and rising adoption of anti-inflammatory drugs. According to a recent study report published by the Market Research Future, the Clinical Laboratory Test market is booming and expected to gain prominence over the forecast period. The market is forecast to demonstrate a spectacular growth by 2022, surpassing its previous growth records in terms of value with a striking CAGR during the anticipated period (2017 – 2022). Clinical laboratory test market   has emerged as the most growing segment of healthcare over the past few years. Clinical laboratory testing includes all routine check-ups and other pathology tests for the diagnosis of various diseases ranging from CBC and other routine blood test, anatomical pathological testing, molecular, immunological, drug testing and other tests for disease diagnosis and treatment. CBC and other routine blood tests are the most common type of tests that scre

  Market Overview This impressive CAGR is possible due to the increasing number of household pets, the rising demand for humane practices in livestock management, and the easing of restrictions governing the use of CBD products to treat various ailments. The market for global veterinary CBD products is already very diverse with multiple channels of sale. The  Global Veterinary CBD Market   is poised to register a  CAGR of 129.97%  during the forecast period. SEGMENTATION By Source CBD products are derived from two principle sources. Each source produces its own strain and strength of CBD-related products and independently rank within the legal framework of nations. By Product There is a vast array of veterinary CBD products available in the market. By Distribution Channel The growth of the global veterinary CBD market is directly impacted by the distribution channels. By Region The global veterinary cbd market reviews is currently concentrated in North America

  Human Insulin Market – Overview Human insulin is also known as synthetic insulin which is prepared in laboratory and has same characteristics like natural insulin. Human insulin was developed through the 1960s and 1970s and approved for pharmaceutical use in 1982. Before the invention of human insulin animal insulin, usually a purified form of porcine was used. Today, approximately 100 million people around the world need insulin, including all people living with type 1 diabetes and between 10-25 percent of people with type 2 diabetes. Although recombinant human insulin has been used in the treatment of diabetes for over 90 years, globally more than half of those who need insulin today still cannot afford it. Without insulin, people living with type 1 diabetes will die. Many more will suffer from diabetes-related complications, like blindness, amputation and kidney failure, and, ultimately, premature death. There are many complex issues that affect access to this life-saving med

  Market Highlights Lung cancer is a malignant lung tumor characterized by uncontrolled cell growth in lung tissue with symptoms such as coughing, weight loss, fatigue and chest pain. The two types of lung cancers are small-cell lung carcinoma (SCLC) and non-small-cell lung carcinoma (NSCLC). The NSCLC type accounts for almost 80% of the cancers with NSCLC representing the remaining. The cure rates for the two types of lung cancers exchange their positions with the SCLC being the most malignant. The cure rates also depend on the stage of cancer detection with rates varying by 55% for first stage to just 1% for stage four. Almost 85% of cases of lung cancer market are due to long-term tobacco smoking. Cigarette smoke contains at least 73 known carcinogens. Other factors causing lung cancer are genetic factors and exposure to triggers and carcinogens such as radon gas, asbestos, radioactive materials, second-hand smoke, or air pollution. It has also been demonstrated that passive

  Ambulatory Services Market Overview Ambulatory service or ambulatory care is a broad term used to describe medical care performed at the OPDs or on an outpatient basis, without admission to a hospital or other facility.   Ambulatory Care Services Centers only treat patients with chronic or non-severe acute conditions providing dialysis clinics, capital region ambulatory surgery center , hospital outpatient departments, and others. Many medical procedures and surgeries once provided in hospitals have shifted to ambulatory services thanks to technology advancements. Ambulatory services executives coordinate all aspects of outpatient care instead of Doctors and Nurses, making sure the ASC has the strong clinical, financial, and operational footing needed to deliver top-notch patient services. Besides, rapidly undergoing through transformations, advancements in genetics, biomedical, and information technology; Healthcare sector is ushering towards effective personalized treatments